fbpx

September 4, 2020, Utrecht, The Netherlands

Each year, at the occasion of the Annual Congress of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), MILabs chooses an image that exemplifies highly promising advances in the field of in vivo preclinical imaging. This year, among numerous entries, there were many new multi-isotope PET-SPECT and radiotheranostic applications as well as contributions relevant to SARS-CoV-2-virus research, which initiated a worldwide preclinical research effort.

Due to the vast number of  entries related to pulmonary research relevant to SARS-Cov-2 virus imaging, multiple pulmonary contributions were selected as the co-images for the MILabs Preclinical Image of the Year award:

Co-winner #1 – Ferrets have emerged as an indispensable model for the study of respiratory diseases, including Covid-19. Researchers at the University of Alabama demonstrated how quantitative pulmonary imaging in ferrets using the MILabs U-CT system could be accomplished. The research team includes: Denise Stanford, Harrison Kim, Sandeep Bodduluri, Jennifer LaFontaine, Stephen A. Byzek, Trenton R. Schoeb, Elex S. Harris, Hrudaya P. Nath, Surya P. Bhatt, S. Vamsee Raju, and Steven M. Rowe and the article can be found here https://journals.physiology.org/doi/full/10.1152/ajplung.00328.2019

Co-winner #2 – While high-resolution in vivo CT is used for many pulmonary research applications, the use of molecular tracers can add critical extra information. The University of British Columbia ranked different quantitative pulmonary administration methods of nuclear tracers to mouse models using the MILabs VECTorCT imaging platform. The research team includes: Lan Wu, Cristina Rodríguez-Rodríguez, Dongmei Cun, Mingshi Yang, Katayoun Saatchi, Urs O Häfeli and the article can be found here: https://pubmed.ncbi.nlm.nih.gov/32437751/

Co-winner #3 – In a joint effort, TU Delft and UMC Utrecht developed virtual lung endoscopy methods to localize pathological processes in the bronchi of mice, guinea pigs, and ferrets. The image can be found here: https://www.milabs.com/image-gallery/#elementor-action:action=lightbox&settings=eyJpZCI6IjAwMWMxMWMiLCJ1cmwiOiJodHRwczovL3d3dy5taWxhYnMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy83LmdpZiJ9

MILabs B.V. congratulates the winners and already looks forward to the terrific in vivo images that will be generated over the coming years.

About MILabs B.V.

This fast-growing Dutch company has a history of providing a continuum of innovations to expand the applications of preclinical molecular imaging. With its latest adaptive platform, MILabs has succeeded at commercializing a scalable imaging platform, able to accommodate exclusive Optical tomography and ultra-high-resolution CT imaging as well as high-definition nuclear PET and SPECT techniques. The company has built a strong brand based on its mission of “Making Molecular Imaging Clear” complemented by multiparametric imaging and unique concurrent within a subject analysis of multiple probes. It provides efficient translational systems for both diagnostic and therapeutic applications while minimizing the use of animal models. For more information, visit:  www.milabs.com or contact MILabs at [email protected]

Share on social media
Share on facebook
Share on twitter
Share on linkedin
Share on email

Spotlight on Prof. Twan Lammers – ExMI-RWTH Aachen

A Pioneering Mind in Nanomedicine and Theranostics Prof. Dr. Dr. Twan Lammers is Head of …

Read More →

Miltenyi Biotec strengthens its research capabilities for cell analysis and preclinical imaging by acquiring a MILabs’ premium Optical/CT imaging system

  Utrecht and Bergisch Gladbach, September 9, 2020 Miltenyi Biotec B.V. & Co. KG, a …

Read More →

MILabs announced the co-winners of the MILabs Image of the Year Award

September 4, 2020, Utrecht, The Netherlands Each year, at the occasion of the Annual Congress …

Read More →

Bayer AS installs top-of-the-line MILabs VECTor PET/SPECT/CT to advance its targeted alpha therapy programs

August 27, 2020, Oslo-Norway and Utrecht-The Netherlands Bayer AS has installed a state-of-the-art MILabs VECTor …

Read More →

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam On the frontline of fighting …

Read More →

The University of Southampton enters the field of Correlative In-Vivo Imaging by acquiring MILabs 3D/4D Optical/CT

May 12, 2020, Southampton, UK – Utrecht, the Netherlands The Faculty of Medicine, University of …

Read More →

MILabs remotely installs from the Netherlands new E-Class PET/SPECT/CT at Osaka University of Pharmaceutical Sciences

Osaka, Japan and Utrecht, the Netherlands May 4th, 2020 In a world with COVID-19 travel …

Read More →

University of Torino (UNITO) acquires an advanced MILabs molecular imaging system

The University of Torino (UNITO) acquires advanced MILabs molecular imaging system for the design of …

Read More →

Truman VA acquires VECTor preclinical imaging system featuring exclusive multimodal synergy capabilities.

Columbia, Missouri, USA and Utrecht, the Netherlands April 9th, 2020 Harry S. Truman Memorial Veterans’ …

Read More →

Cyprus-based EPOS-Iasis acquires MILabs innovative Optical/CT system

Aimed at achieving a paradigm shift in Oncology research by imaging and quantifying fluorescent signals …

Read More →

MILabs enhances micro-CT for Coronavirus (COVID-19) research.

March 19, 2020 – Utrecht, the Netherlands Based on recent scientific research, diagnostic X-ray CT …

Read More →

The Julius Wolf Institute at the Charité installs mission-critical MILabs microCT for in-vivo studies of musculoskeletal regeneration

25 February 2020 – Berlin-Germany and Utrecht, Netherlands, The Julius Wolff Institute for Biomechanics and …

Read More →
Scroll to Top